Carbapenem-resistant Acinetobacter baumannii (CRAB) are an increasing infectious threat
in hospitals. We investigated the clinical epidemiology of CRAB infections vs. colonization in …

Multidrug-resistant Acinetobacter baumannii has emerged as a serious nosocomial
pathogen in certain areas. In Brooklyn, New York, citywide surveillance revealed that∼ 2 of …

In total, 96 carbapenem-resistant isolates of Acinetobacter baumannii were obtained from 25
hospitals in 17 European countries. Imipenem MICs ranged from< 4 to 128 mg/L on retesting …

Acinetobacter baumannii is an opportunistic gram-negative pathogen with increasing
relevance in a variety of nosocomial infections especially among intensive-care-unit (ICU) …

Carbapenem-resistant Acinetobacter baumannii (CRAB) presents a serious therapeutic and
infection control challenge. In this study, we investigated the epidemiological and molecular …

Objectives We have investigated the molecular epidemiology and distribution of
carbapenemase genes in 492 imipenem-non-susceptible Acinetobacter baumannii …

Beginning in 1992, a sustained outbreak of multiresistant Acinetobacter baumannii
infections was noted in our 1,000-bed hospital in Barcelona, Spain, resulting in considerable …

Carbapenems are considered the treatment of choice for Acinetobacter baumannii
infections. Many facilities implement preventive measures toward only carbapenem-resistant …

We describe the first emergence of carbapenem-resistant Acinetobacter baumannii in
Australia. Ninety A. baumannii isolates recovered from cultures of blood specimens from 69 …

This study analysed the occurrence of carbapenem resistance among Acinetobacter
baumannii isolates from a tertiary-care hospital in Poland, together with the molecular …